MAGICL 25-OH-VD (CLIA) is intended for the in vitro quantitative determination of total 25-hydroxyvitamin D (25-OH-VD) in human serum or plasma, whole blood, or capillary blood samples.
MAGICL FDP (CLIA) is intended for the in vitro quantitative determination of Fibrin/fibrinogen degradation products (FDP) in human plasma and whole blood.
MAGICL TAT (CLIA) is intended for the in vitro quantitative detecting the activity or content of thrombin-antithrombin Ⅲ complex (TAT) in human plasma and whole blood samples.
MAGICL PIC (CLIA) is intended for the in vitro quantitative determination of plasmin-α2 plasmin inhibitor complex (PIC) in human plasma or whole blood.
MAGICL t-PAIC (CLIA) is intended for the in vitro quantitatively determination of Tissue plasminogen activator-Plasminogen activator inhibitor Complex (t-PAIC) in human plasma and whole blood.
MAGICL TNF-α (CLIA) is intended for the in vitro quantitative determination of tumor necrosis factor alpha (TNF-α) in human serum, plasma and whole blood.
MAGICL 25-OH-VD (CLIA) is intended for the in vitro quantitative determination of total 25-hydroxyvitamin D (25-OH-VD) in human serum or plasma, whole blood, or capillary blood samples.
MAGICL FDP (CLIA) is intended for the in vitro quantitative determination of Fibrin/fibrinogen degradation products (FDP) in human plasma and whole blood.
MAGICL TAT (CLIA) is intended for the in vitro quantitative detecting the activity or content of thrombin-antithrombin Ⅲ complex (TAT) in human plasma and whole blood samples.
MAGICL PIC (CLIA) is intended for the in vitro quantitative determination of plasmin-α2 plasmin inhibitor complex (PIC) in human plasma or whole blood.
MAGICL t-PAIC (CLIA) is intended for the in vitro quantitatively determination of Tissue plasminogen activator-Plasminogen activator inhibitor Complex (t-PAIC) in human plasma and whole blood.
MAGICL TNF-α (CLIA) is intended for the in vitro quantitative determination of tumor necrosis factor alpha (TNF-α) in human serum, plasma and whole blood.
